APA

Grassi F., Guimarães Corrêa A. B., Mascarenhas R. E., Galvão B., Séon-Méniel B., Schmidt F., Franck X., Hocquemiller R., Figadère B. & Fournet A. (20090122). Quinoline compounds decrease in vitro spontaneous proliferation of peripheral blood mononuclear cells (PBMC) from human T-cell lymphotropic virus (HTLV) type-1-infected patients. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Chicago

Grassi Fernanda, Guimarães Corrêa Ana Beatriz, Mascarenhas Rita Elizabeth, Galvão Bernardo, Séon-Méniel Blandine, Schmidt Fanny, Franck Xavier, Hocquemiller Reynald, Figadère Bruno and Fournet Alain. 20090122. Quinoline compounds decrease in vitro spontaneous proliferation of peripheral blood mononuclear cells (PBMC) from human T-cell lymphotropic virus (HTLV) type-1-infected patients. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Harvard

Grassi F., Guimarães Corrêa A. B., Mascarenhas R. E., Galvão B., Séon-Méniel B., Schmidt F., Franck X., Hocquemiller R., Figadère B. and Fournet A. (20090122). Quinoline compounds decrease in vitro spontaneous proliferation of peripheral blood mononuclear cells (PBMC) from human T-cell lymphotropic virus (HTLV) type-1-infected patients. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

MLA

Grassi Fernanda, Guimarães Corrêa Ana Beatriz, Mascarenhas Rita Elizabeth, Galvão Bernardo, Séon-Méniel Blandine, Schmidt Fanny, Franck Xavier, Hocquemiller Reynald, Figadère Bruno and Fournet Alain. Quinoline compounds decrease in vitro spontaneous proliferation of peripheral blood mononuclear cells (PBMC) from human T-cell lymphotropic virus (HTLV) type-1-infected patients. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 20090122.